Xiaofang J. Wang

State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College, Tianjin 300020
Tianjin, 301600, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications

Clinical characteristics and prognosis of myelodysplastic neoplasms with GATA2 mutations

Clinical characteristics and prognosis of myelodysplastic neoplasms with GATA2 mutations

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: July 06, 2026

Molecular and clinical characteristics and prognosis of myelodysplastic neoplasms with biallelic TET2 inactivation

Molecular and clinical characteristics and prognosis of myelodysplastic neoplasms with biallelic TET2 inactivation

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: May 20, 2026

Treatment prioritization of chemotherapy-anchored regimens after EGFR-TKI failure in EGFR-mutant NSCLC: a systematic review, pairwise meta-analysis and Bayesian network meta-analysis with probabilistic multi-criteria decision analysis.

Treatment prioritization of chemotherapy-anchored regimens after EGFR-TKI failure in EGFR-mutant NSCLC: a systematic review, pairwise meta-analysis and Bayesian network meta-analysis with probabilistic multi-criteria decision analysis.

Journal: Frontiers in immunology
Published: April 24, 2026

Prognostic value of the FS-15 frailty score in patients with myelodysplastic syndromes

Prognostic value of the FS-15 frailty score in patients with myelodysplastic syndromes

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: October 27, 2025

Author Correction: Cancer biomarkers discovered using pan-cancer plasma proteomic profiling.

Author Correction: Cancer biomarkers discovered using pan-cancer plasma proteomic profiling.

Journal: Nature biomedical engineering
Published: September 22, 2025

Single cell profiling reveals malignant states and immune landscapes in PCNSL and systemic DLBCL.

Single cell profiling reveals malignant states and immune landscapes in PCNSL and systemic DLBCL.

Journal: iScience
Published: August 11, 2025

Ferroptotic resistance involved in PTEN-loss prostate cancer progression.

Ferroptotic resistance involved in PTEN-loss prostate cancer progression.

Journal: Discover oncology
Published: June 05, 2025

p53/PD-L1 co-expression predicts poor prognosis in diffuse large B-cell lymphoma.

p53/PD-L1 co-expression predicts poor prognosis in diffuse large B-cell lymphoma.

Journal: Discover oncology
Published: March 20, 2025

Heterogeneity of high-potency multilineage hematopoietic stem cells and identification of "Super" transplantability.

Heterogeneity of high-potency multilineage hematopoietic stem cells and identification of "Super" transplantability.

Journal: Blood
Published: December 02, 2024

Follicular lymphoma grade 3A: aggressiveness and curability in an Asian cohort of 781 patients.

Follicular lymphoma grade 3A: aggressiveness and curability in an Asian cohort of 781 patients.

Journal: Annals of hematology
Published: November 11, 2024

Early megakaryocyte lineage-committed progenitors in adult mouse bone marrow.

Early megakaryocyte lineage-committed progenitors in adult mouse bone marrow.

Journal: Blood science (Baltimore, Md.)
Published: December 20, 2023

Overexpression of ornithine decarboxylase 1 mediates the immune-deserted microenvironment and poor prognosis in diffuse large B-cell lymphoma.

Overexpression of ornithine decarboxylase 1 mediates the immune-deserted microenvironment and poor prognosis in diffuse large B-cell lymphoma.

Journal: Journal of the National Cancer Center
Published: October 13, 2023
Showing 1-12 of 59

Last Updated: 09/26/2026